| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2005 | US6884910 Uses for amino acid anticonvulsants |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884888 Reacting mixture of N-(3-(3-(dimethylamino)-1-oxo-2-propenyl)phenyl)-N-ethylacetamide and 3-amino-4-cyanopyrazole in a liquid reaction medium; recovering |
| 04/26/2005 | US6884819 Administering to a Alzheimer's patient an effective amount of a (15R)-isocarbacycline compound to treat the disease |
| 04/26/2005 | US6884818 Administering to a patient suffering from hypercholesterolaemia a cloricromene or pharaceutically acceptable salt as anticholesterol agent |
| 04/26/2005 | US6884817 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases |
| 04/26/2005 | US6884816 Seretonin receptor antagonists |
| 04/26/2005 | US6884813 Microbiocides used to treat eye and skin infections |
| 04/26/2005 | US6884810 Benzimidazole derivatives |
| 04/26/2005 | US6884809 Method and compositions for reducing cardiac dysfunctions with a selective histamine H3 receptor agonist |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884805 Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884799 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof |
| 04/26/2005 | US6884797 Targeted oxidative therapeutic formulation |
| 04/26/2005 | US6884796 Useful for relieving infertility in females and males |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 04/26/2005 | US6884793 Combination preparation for contraception based on natural estrogens |
| 04/26/2005 | US6884788 Thiol-modified hyaluronan |
| 04/26/2005 | US6884784 Diagnosis and management of infection caused by chlamydia |
| 04/26/2005 | US6884783 7-Hydroxy chromones as potent antioxidants |
| 04/26/2005 | US6884779 Hybrid screening analyzing |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884770 Prophylaxis of nerve system disorders comprising administering to animals hedgehog proteins having amino acid sequences that bind to receptors and promote hedgehog signal transduction |
| 04/26/2005 | US6884769 Administering enzyme inhibitors or cell growth regulators for prophylaxis of bone disorders |
| 04/26/2005 | US6884768 Using taurine compound; adjust bioavailability; prevent, suppression damage to intestine mucous membrane |
| 04/26/2005 | US6884596 A compound that is a Prolactin Releasing Peptide receptor (PrRP) agonist; determining the ability of the compound to promote wakefulness; providing a PrRP receptor antagonist and determining the ability of the compound to promote sleep |
| 04/26/2005 | US6884577 Methods for screening compounds for estrogenic activity |
| 04/26/2005 | US6884445 Matrix-forming composition containing pectin |
| 04/26/2005 | US6884440 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time |
| 04/26/2005 | US6884439 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 04/26/2005 | US6884438 Encapsulation of a drug by nanocapsules being dispersible in aqueous phase in colloidal form, nontoxic, biocompatible, stable in colloidal suspension and economical and prepared using two non-oily solvents and an oily solvent; time-release |
| 04/26/2005 | US6884437 Administration form comprising an acid-labile active compound |
| 04/26/2005 | US6884436 Mixing a solution of a drug with a second solvent to precipitate the drug and seeding |
| 04/26/2005 | US6884434 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884424 Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
| 04/26/2005 | US6884421 Butyric acid, wheat fibre bran and guar gum |
| 04/26/2005 | US6884420 Antidiabetic agents contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium |
| 04/26/2005 | US6884412 Dectection of and methods and composition for prevention and/or treatment of papillomatous digital dermatitis |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | US6883516 Preparing solution of first component in liquid component such that after volatilization of liquid by passing solution through flow passage while heating, aerosol is formed having predetermined particle size distribution of first component |
| 04/26/2005 | CA2255222C Use of phloroglucinol in a composition |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2244134C Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/26/2005 | CA2216810C Method for treatment of benign prostatic hypertrophy |
| 04/26/2005 | CA2209487C Imidazo[4,5-c]quinoline amines |
| 04/26/2005 | CA2165830C Salmeterol xinafoate with controlled particle size |
| 04/26/2005 | CA2144728C Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium |
| 04/26/2005 | CA2125251C A pharmaceutical composition for angiotensin ii-mediated diseases |
| 04/26/2005 | CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 04/26/2005 | CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation |
| 04/21/2005 | WO2005035779A2 Method |
| 04/21/2005 | WO2005035764A1 Autogene nucleic acids encoding a secretable rna polymerase |
| 04/21/2005 | WO2005035731A2 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists |
| 04/21/2005 | WO2005035606A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 04/21/2005 | WO2005035574A1 IgM HIGH CONCENTRATION STABILIZED SOLUTION |
| 04/21/2005 | WO2005035551A2 Inhibitors of proteins that bind phosphorylated molecules |
| 04/21/2005 | WO2005035548A1 The moduilation of hyaluronan synthesis and degradation in the treatment of disease |
| 04/21/2005 | WO2005035542A1 Solid-state form of alendronate sodium and preparation thereof |
| 04/21/2005 | WO2005035537A2 Substituted tricyclic heterocycles and their uses |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035531A1 POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION |
| 04/21/2005 | WO2005035528A2 Triazole derivatives as antibacterial agents |
| 04/21/2005 | WO2005035525A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035520A1 Substituted isoquinolinones |
| 04/21/2005 | WO2005035516A1 Novel fused heterocyclic compound and use thereof |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035512A1 Thiadiazoline derivatives |
| 04/21/2005 | WO2005035511A1 N-desmethyl levomepromazine |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | WO2005035506A1 Novel indazole derivative |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035501A1 Novel olefin derivative |
| 04/21/2005 | WO2005035500A2 Therapeutic agents useful for treating pain |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005035496A1 Process for the preparation of n-amino substituted heterocyclic compounds |
| 04/21/2005 | WO2005035491A2 PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS FROM 2- VINYLCHROMANE COMPOUND |
| 04/21/2005 | WO2005035490A2 PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS |
| 04/21/2005 | WO2005035477A1 Method of stabilizing compound having quinone skeleton and stabilized composition |
| 04/21/2005 | WO2005035441A2 Subtituted fullerene compositions and their use as antioxydants |
| 04/21/2005 | WO2005035004A1 COMPOSITION FOR INHIBITING FUNCTION OF HUMAN Flt3 |
| 04/21/2005 | WO2005035003A2 Compositions and methods for increasing drug efficiency |
| 04/21/2005 | WO2005035000A1 Methylphenidate solution and associated methods of administration and production |
| 04/21/2005 | WO2005034999A2 Composition comprising association complex of a pharmaceutical and a poloxamer |
| 04/21/2005 | WO2005034998A2 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 04/21/2005 | WO2005034980A1 Glutamine for use in treating injury |
| 04/21/2005 | WO2005034979A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | WO2005034976A1 Antimicrobial compositions and methods of use |
| 04/21/2005 | WO2005034975A1 Plant seed extract composition and process for producing the same |